TLR4 Targeting: A Promising Therapeutic Approach Across Multiple Human Diseases.

TLR4 stands at the forefront of innate immune responses, recognizing various pathogen- associated molecular patterns and endogenous ligands, thus serving as a pivotal mediator in the immune system's defense against infections and tissue damage. Beyond its canonical role in infection, emerging evidence highlights TLR4's involvement in numerous non-infectious human diseases, ranging from metabolic disorders to neurodegenerative conditions and cancer. Targeting TLR4 signaling pathways presents a promising therapeutic approach with broad applicability across these diverse pathological states.

Redefining Chronic Disease Care: Unleashing the Potential of Phytomedicines.

Phytomedicines represent a diverse array of plant-derived compounds renowned for their therapeutic potential. Traditionally, these mixtures were extracted using water or ethanol, but simpler methods like tea infusions are gaining prominence. However, ensuring the efficacy and safety of phytomedicines demands high-quality plant material and stringent production processes.

Intravitreal methotrexate as an adjuvant in vitrectomy in cases of retinal detachment with proliferative vitreoretinopathy.

Purpose: To compare the rate of re-detachment in patients with rhegmatogenous retinal detachment and Grade-C PVR following vitreoretinal surgery, with and without serial intravitreal injections of methotrexate.

Methods: It was a randomized control trial. Patients aged more than 18 years undergoing pars plana vitrectomy for rhegmatogenous retinal detachment with PVR grade C or more were included in the study.